The Journal of Organic Chemistry
Page 6 of 9
5-Ethoxy-4-(4-methoxyphenyl)furan-3(2H)-one & 5-ethoxy-
4-(3-methoxyphenyl)furan-3(2H)-one (13). Following the
general experimental procedure, 4-methoxy-2-
chloroacetoacetate 2b (100 mg, 0.66 mmol), KF (192 mg, 5.0
equiv.), 18C-6 (872 mg, 5.0 equiv.) in CH3CN (4.0 mL) at 0
oC and subsequent stirring at room temperature for 5 h. The
crude product was purified over silica gel (100-200 mesh)
column chromatography (30% ethyl acetate in hexanes) to
afford the desired product 16 as a pale brown solid and as
regioisomers in a ratio of 1:1 (101 mg, 75%). Analytical data
of 16. Mp: 57-59 C. H NMR (300 MHz, CDCl3, TMS): δ
7.66-7.62 (m, 2H), 7.59-7.58 (m, 1H), 7.54-7.51 (m, 1H),
7.20-7.14 (m, 1H), 7.11-7.08 (m, 2H), 6.96-6.93 (m, 1H), 4.61
(s, 2H), 4.60 (s, 2H), 4.10 (s, 3H), 4.10 (s, 3H), 2.29 (s, 3H),
2.26 (s, 3H) ppm. 13C{1H} NMR (75 MHz, CDCl3): 194.2,
194.2, 180.8, 180.7, 137.7, 135.7, 129.0, 128.9, 128.1, 126.9,
126.7, 126.2, 125.9, 123.2, 94.2, 94.0, 74.7, 56.6, 56.6, 21.6,
21.2 ppm. HRMS (EI) m/z: (M)+ calcd for C12H12O3
204.0786; Found: 204.0796.
1
2
3
4
5
6
7
8
(trimethylsilyl)phenyl triflate 1g (250 mg, 1.25 equiv.), ethyl-
4-chloroacetoacetate 2a (100 mg, 0.61 mmol), KF (177 mg,
5.0 equiv.), 18C-6 (806 mg, 5.0 equiv.) in CH3CN (4.0 mL) at
o
0 C and subsequent stirring at room temperature for 5 h. The
o
1
crude product was purified over silica gel (100-200 mesh)
column chromatography (30% ethyl acetate in hexanes) to
afford the desired product 13 as a pale yellow solid and as
regioisomers in a ratio of 1.3:1 (96 mg, 67%). Analytical data
9
o
1
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
of 13. Mp: 132-134 C. H NMR (300 MHz, CDCl3, TMS): δ
7.74-7.69 (m, 2.6H), 7.45-7.44 (m, 1H), 7.41-7.38 (m, 1H),
7.22-7.17 (m, 1H), 6.86-6.81 (m, 2.6H), 6.70-6.66 (m, 1H),
4.59 (s, 2H), 4.58 (s, 2.6H), 4.55-4.46 (m, 4.6H), 3.75 (s, 3H),
3.73 (s, 3.9H) 1.47-1.41 (m, 7H) ppm. 13C{1H} NMR (75
MHz, CDCl3): 194.2, 194.0, 180.6, 180.2, 159.4, 157.7, 130.8,
129.1, 127.2, 121.9, 118.4, 113.7, 111.7, 111.3, 93.7, 93.6,
74.5, 74.5, 66.7, 66.5, 55.2, 55.1, 14.9, 14.8 ppm. HRMS (EI)
m/z: (M)+ calcd for C13H14O4 234.0892; Found: 234.0888.
4-(4-Chlorophenyl)-5-ethoxyfuran-3(2H)-one
chlorophenyl)-5-ethoxyfuran-3(2H)-one (17). Following the
general experimental procedure, 4-chloro-2-
&
4-(3-
(trimethylsilyl)phenyl trifluoromethanesulfonate 1i (254 mg,
1.25 equiv.), ethyl-4-chloroacetoacetate 2a (100 mg, 0.61
mmol), KF (177 mg, 5.0 equiv.), 18C-6 (806 mg, 5.0 equiv.)
5-Methoxy-4-(4-methoxyphenyl)furan-3(2H)-one
methoxy-4-(3-methoxyphenyl)furan-3(2H)-one (14). Following
the general experimental procedure, 4-methoxy-2-
&
5-
o
in CH3CN (4.0 mL) at 0 C for 4 h. The crude product was
(trimethylsilyl)phenyl triflate 1g (271 mg, 1.25 equiv.),
methyl-4-chloroacetoacetate 2b (100 mg, 0.66 mmol), KF
(192 mg, 5.0 equiv.), 18C-6 (872 mg, 5.0 equiv.) in CH3CN
purified over silica gel (100-200 mesh) column
chromatography (30% ethyl acetate in hexanes) to afford the
desired product 17 as a pale yellow oil and as regioisomers in
a ratio of 1:1.2 (90 mg, 62%). Analytical data of 17. TLC
o
(4.0 mL) at 0 C and subsequent stirring at room temperature
1
for 5 h. The crude product was purified over silica gel (100-
200 mesh) column chromatography (30% ethyl acetate in
hexanes) to afford the desired product 14 as a pale yellow and
as regioisomers in a ratio of 1.8:1 (102 mg, 70%). Analytical
data of 14. Mp: 86-88 oC. 1H NMR (300 MHz, CDCl3, TMS):
δ 7.71-7.66 (m, 3.7H), 7.42-7.41 (m, 1H), 7.39-7.35 (m, 1H),
7.22-7.17 (m, 1H), 6.86-6.81 (m, 3.8H), 6.71-6.67 (m, 1H),
4.61 (s, 2H), 4.60 (s, 3.6H), 4.12 (s, 3H), 4.10 (s, 5.7H), 3.75
(s, 3H), 3.73 (s, 5.6H). 13C{1H} NMR (75 MHz, CDCl3):
194.2, 180.5, 159.5, 157.8, 130.6, 129.1, 127.3, 121.7, 118.5,
113.7, 111.7, 111.5, 93.9, 74.7, 56.6, 55.2 ppm. HRMS (ESI)
m/z: (M+H)+ calcd for C12H13O4 221.0808; Found: 221.0808.
(SiO2): Rf 0.38 (50% ethyl acetate in hexane). H NMR (300
MHz, CDCl3, TMS): δ 7.82-7.81 (m, 1H), 7.79-7.72 (m,
3.6H), 7.26-7.19 (m, 3.4H), 7.10-7.06 (m, 1H), 4.61 (s, 2H),
4.61 (s, 2.4H), 4.58-4.40 (m, 4.4H), 1.49-1.43 (m, 6.6H) ppm.
13C{1H} NMR (75 MHz, CDCl3): 194.0, 193.8, 180.6, 180.5,
134.0, 131.3, 131.3, 129.4, 128.3, 128.0, 127.0, 125.9, 125.6,
123.7, 93.0, 92.8, 74.7, 67.1, 67.0, 14.8 ppm. HRMS (ESI)
m/z: (M)+ calcd for C12H12ClO3 239.0469; Found: 239.0469.
4-(4-Chlorophenyl)-5-methoxyfuran-3(2H)-one
chlorophenyl)-5-methoxyfuran-3(2H)-one (18). Following the
general experimental procedure, 4-chloro-2-
&
4-(3-
(trimethylsilyl)phenyl trifluoromethanesulfonate 1i (275 mg,
1.25 equiv.), methyl-4-chloroacetoacetate 2b (100 mg, 0.66
mmol), KF (192 mg, 5.0 equiv.), 18C-6 (872 mg, 5.0 equiv.)
5-Ethoxy-4-(p-tolyl)furan-3(2H)-one
tolyl)furan-3(2H)-one (15). Following
&
5-ethoxy-4-(m-
the general
o
experimental procedure, 4-methyl-2-(trimethylsilyl)phenyl
trifluoromethanesulfonate 1h (238 mg, 1.25 equiv.), ethyl-4-
chloroacetoacetate 2a (100 mg, 0.61 mmol), KF (177 mg, 5.0
equiv.), 18C-6 (806 mg, 5.0 equiv.) in CH3CN (4.0 mL) at 0
oC and subsequent stirring at room temperature for 5 h. The
crude product was purified over silica gel (100-200 mesh)
column chromatography (30% ethyl acetate in hexanes) to
afford the desired product 15 as a pale brown solid and as
regioisomers in a ratio of 1:1 (95 mg, 71%). Analytical data of
15. Mp: 75-77 oC. 1H NMR (300 MHz, CDCl3, TMS): δ 7.69-
7.64 (m, 2H), 7.63-7.62 (m, 1H), 7.55-7.52 (m, 1H), 7.20-7.15
(m, 1H), 7.11-7.07 (m, 2H), 6.96-6.93 (m, 1H), 4.59 (s, 2H),
4.59 (s, 2H), 4.54-4.46 (m, 4H), 2.29 (s, 3H), 2.26 (s, 3H)
1.46-1.41 (m, 6H) ppm. 13C{1H} NMR (75 MHz, CDCl3):
194.2, 194.2, 180.6, 180.5, 137.7, 135.5 129.2, 128.9, 128.1,
126.8, 126.7, 126.4, 125.9, 123.1, 94.0, 93.9, 74.5, 66.6, 66.5,
21.6, 21.2, 14.8 ppm. HRMS (EI) m/z: (M)+ calcd for
C13H14O3 218.0937; Found: 218.0926.
in CH3CN (4.0 mL) at 0 C for 4 h. The crude product was
purified over silica gel (100-200 mesh) column
chromatography (30% ethyl acetate in hexanes) to afford the
desired product 18 as a pale yellow oil and as regioisomers in
a ratio of 1:1.4 (101 mg, 66%). Analytical data of 18. TLC
1
(SiO2): Rf 0.32 (50% ethyl acetate in hexane). H NMR (300
MHz, CDCl3, TMS): δ 7.79-7.77 (m, 1H), 7.76-7.71 (m,
3.8H), 7.25-7.17 (m, 3.8H), 7.10-7.07 (m, 1H), 4.62 (s, 2H),
4.62 (s, 2.8H), 4.14 (s, 3H), 4.13 (s, 4.2H) ppm. 13C{1H} NMR
(75 MHz, CDCl3): 193.9, 193.7, 180.9, 180.8, 134.1, 131.4,
131.1, 129.4, 128.3, 127.8, 127.1, 126.0, 125.6, 123.8, 93.2,
93.0, 74.8, 56.9, 56.9 ppm. HRMS (EI) m/z: (M)+ calcd for
C11H9ClO3 224.0240; Found: 224.0252.
5-ethoxy-2-methyl-4-phenylfuran-3(2H)-one
(19).
Following the general experimental procedure, 2-
(trimethylsilyl) phenyl trifluoromethanesulfonate 1a (167 mg,
1.25 equiv.), ethyl 4-bromo-3-oxopentanoate 2c (100 mg, 0.45
mmol), KF (130 mg, 5.0 equiv.), 18C-6 (592 mg, 5.0 equiv.)
o
5-Methoxy-4-(p-tolyl)furan-3(2H)-one & 5-methoxy-4-(m-
in CH3CN (3.0 mL) at 0 C and subsequent stirring at room
tolyl)furan-3(2H)-one
(16).
Following
the
general
temperature for 5 h. The crude product was purified over silica
gel (100-200 mesh) column chromatography (30% ethyl
acetate in hexanes) to afford the desired product 19 as a pale
experimental procedure, 4-methyl-2-(trimethylsilyl)phenyl
trifluoromethanesulfonate 1h (258 mg, 1.25 equiv.), methyl-4-
ACS Paragon Plus Environment